md-medicaldata

Authors

 

Marko Antunović^1,2, Marijana Ćurčić³, Predrag Aleksić^4,2, Vladimir Bančević^4,2, Snežana Đorđević<sup>1,2

1</sup> Nacionalni centar za kontrolu trovanja, Vojnomedicinska akademija, Beograd, Srbija
² Medicinski fakultet, Vojnomedicinska akademija, Univerzitet odbrane, Beograd, Srbija
³ Univerzitet u Beogradu, Farmaceutski fakultet, Katedra za toksikologiju "Akademik Danilo Soldatović", Beograd ,Srbija
⁴ Klinika za urologiju, Vojnomedicinska akademija, Beograd, Srbija

 

UDK: 616.62-006.6-02

The paper recieved / Rad primljen: 02.06.2018.

Accepted / Rad prihvaćen: 15.06.2018.

 

Corresponding to:

Marko Antunović
Nacionalni centar za kontrolu trovanja
Vojnomedicinska akademija, Crnotravska 17,
11 000 Beograd, Srbija
e-mail: antunovic.marko87@gmail.com

 

Sažetak

 

Karcinom bešike spada u najčešće tumore mokraćnih organa i čest je uzrok mortaliteta i morbiditeta u celom svetu. Može se pojaviti u bilo kom uzrastu, ali najčešće se javlja kod sredovečnih i starijih pacijenata muškog pola. Najviše stope oboljevanja navode se u razvijenim zemljama Evrope, Severne Amerike i u Australiji. Kao i sve druge maligne bolesti, karcinom bešike se javlja kao posledica interakcije genetskih i sredinskih faktora. Jedan od glavnih faktora rizika koji se prijavljuje u većini slučajeva novobolelih je pušenje. Od ostalih faktora rizika navode se profesionalna, kao i ekspozicija opšte populacije različitim hemikalijama, konzumiranje određenih namirnica, upotreba nekih lekova i dr. Buduća istraživanja trebalo bi da ispitaju kakvu ulogu imaju ovi faktori rizika kako bi se razumeli komplikovani mehanizmi karcinogeneze mokraćne bešike. Imajući u vidu da glavnu ulogu u karcinogenezi imaju sredinski faktori, logično je zaključiti da bi se promenom životnih navika i poboljšanjem radnih uslova smanjila incidenca oboljevanja od karcinoma bešike.

 

 

Ključne reči:

karcinom bešike, pušenje, profesionalna izloženost, prevencija; Polymorphisms

 

 

Abstract

 

Bladder cancer is common urinary system cancer and frequent cause of mortality and morbidity worldwide. It can appear in any age, but most frequent in older male patients. The highest incidences are reported in developed countries of Western Europe, North America and in Australia. As other malignancy, bladder cancer is result of interaction of genetic and environmental factors. Major risk factor among bladder cancer patients is smoking. Other risk factors reported are: occupational and environmental exposure to various chemicals, diet, specific drug therapy and other. Future research should examine the role of these factors in carcinogenesis of bladder cancer to understand its complicated mechanism. Having in mind, that environmental factors have major role in cancerogenesis, it seems logic to conclude that change of lifestyle and improve of working conditions would decrease incidence of bladder cancer.

 

 

Ključne reči:

bladder cancer, smoking, occupational exposure, prevention

 

 

References:

 

1. Burger M, Catto J, Dalbagni G, Grossman H, Herr H, Karakiewicz P et al. Epidemiology and Risk Factors of Urothelial Bladder Cancer. European Urology. 2013;63(2):234-241.
2. Volanis D, Kadiyska T, Galanis A, Delakas D, Logotheti S, Zoumpourlis V. Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicology Letters. 2010;193(2):131-137.
3. Institut za javno zdravlje Srbije. Incidencija i mortalitet od raka u centralnoj Srbiji, 2015. Beograd: Institut za javno zdravlje; Izveštaj broj17, 2017.
4. Letašiová S, Medveďová A, Šovčíková A, Dušinská M, Volkovová K, Mosoiu C et al. Bladder cancer, a review of the environmental risk factors. Environmental Health. 2012;11(Suppl 1):S11.
5. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database. International Journal of Cancer. 2002;99(2):260-266.
6. Zeegers M, Goldbohm R, van den Brandt P. Cancer Causes and Control. 2002;13(1):83-90.
7. Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon A, Resnick M et al. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. European Urology. 2016;69(2):300-310.
8. Jiang X, Yuan J, Skipper P, Tannenbaum S, Yu M. Environmental Tobacco Smoke and Bladder Cancer Risk in Never Smokers of Los Angeles County. Cancer Research. 2007;67(15):7540-7545.
9. Zeegers M, Kellen E, Buntinx F, van den Brandt P. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World Journal of Urology. 2003;21(6):392-401
10. Golka K, Wiese A, Assennato G, Bolt H. Occupational exposure and urological cancer. World Journal of Urology. 2004;21(6):382-391
11. Ma Q, Lin G, Qin Y, Lu D, Golka K, Geller F et al. GSTP1 A1578G (Ile105Val) polymorphism in benzidine-exposed workers. Pharmacogenetics. 2003;13(7):409-415.
12. Boada L, Henríquez-Hernández L, Navarro P, Zumbado M, Almeida-González M, Camacho M et al. Exposure to polycyclic aromatic hydrocarbons (PAHs) and bladder cancer: evaluation from a gene-environment perspective in a hospital-based case-control study in the Canary Islands (Spain). International Journal of Occupational and Environmental Health. 2014;21(1):23-30
13. Bosetti C, Boffetta P, La Vecchia C. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Annals of Oncology. 2006;18(3):431-446.
14. Kiriluk K, Prasad S, Patel A, Steinberg G, Smith N. Bladder cancer risk from occupational and environmental exposures. Urologic Oncology: Seminars and Original Investigations. 2012;30(2):199-211
15. Feki-Tounsi M, Olmedo P, Gil F, Mhiri M, Rebai A, Hamza-Chaffai A. Trace metal quantification in bladder biopsies from tumoral lesions of Tunisian cancer and controls subjects. Environmental Science and Pollution Research. 2014;21(19):11433-11438.
16. Goebell, P., Villanueva, C., Rettenmeier, A., Robben, H. and Kogevinas, M. (2004). Environmental exposure, chlorinated drinking water, and bladder cancer. World Journal of Urology, 21(6), pp.424-432.
17. Tchounwou P, Centeno J, Patlolla A. Arsenic toxicity, mutagenesis, and carcinogenesis – a health risk assessment and management approach. Molecular and Cellular Biochemistry. 2004;255(1/2):47-55.
18. Feki-Tounsi M, Olmedo P, Gil F, Mhiri M, Rebai A, Hamza-Chaffai A. Trace metal quantification in bladder biopsies from tumoral lesions of Tunisian cancer and controls subjects. Environmental Science and Pollution Research. 2014;21(19):11433-11438.
19. Kellen E, Zeegers M, Hond E, Buntinx F. Blood cadmium may be associated with bladder carcinogenesis: The Belgian case–control study on bladder cancer. Cancer Detection and Prevention. 2007;31(1):77-82.
20. Abdel-Gawad M, Elsobky E, Shalaby M, Abd-Elhameed M, Abdel-Rahim M, Ali-El-Dein B. Quantitative Evaluation of Heavy Metals and Trace Elements in the Urinary Bladder: Comparison Between Cancerous, Adjacent Non-cancerous and Normal Cadaveric Tissue. Biological Trace Element Research. 2016;174(2):280-286.
21. Zeegers M, Kellen E, Buntinx F, van den Brandt P. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World Journal of Urology. 2003;21(6):392-401.
22. Zeegers M, Volovics A, Dorant E, Alexandra Goldbohm R, van den Brandt P. Alcohol Consumption and Bladder Cancer Risk: Results from the Netherlands Cohort Study. American Journal of Epidemiology. 2001;153(1):38-41.
23. Pelucchi C, La Vecchia C. Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies. European Journal of Cancer Prevention. 2009;18(1):62-68.
24. Radosavljevic V, Ilic M, Jankovic S. Epidemiologija I faktori rizika za nastanak raka mokraćne bešike. Vojnosanitetski pregled. 2003;60(2):195-202.
25. Steineck G, Norell S, Feychting M. Diet, Tobacco and Urothelial Cancer: A 14-year follow-up of 16477 subjects. Acta Oncologica. 1988;27(4):323-327.
26. García-Closas R, García-Closas M, Kogevinas M, Malats N, Silverman D, Serra C et al. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. European Journal of Cancer. 2007;43(11):1731-1740.
27. Johansson S, Cohen S. Epidemiology and etiology of bladder cancer. Seminars in Surgical Oncology. 1997;13(5):291-298.
28. Mostafa M, Badawi A, O'Connor P. Bladder cancer associated with Schistosomiasis. Parasitology Today. 1995;11(3):87-89.

PDF Antunović M. et al • MD-Medical Data 2018;10(2): 087-090